Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Vanguard High Dividend Yield ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.96 (market cap $8.48B), while Vanguard High Dividend Yield ETF trades at $159.3 (market cap $100.80B). The key difference: Vanguard High Dividend Yield ETF is far larger — about 11.9× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Vanguard High Dividend Yield ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Vanguard High Dividend Yield ETF for 140 Days on average.
| HNGE | VYM | |
|---|---|---|
Market Cap | $8.48B | $100.80B |
Volume | 879,799 | 834,323 |
Sector | Health | — |
52-Week High | $105.14 | $167.03 |
52-Week Low | $31.17 | $138.43 |
Typical Hold Time | 0 Days | 140 Days |
Enterprise Value | $8.10B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
VYM trades at $159.11, down slightly by 0.08% today, with a bullish technical signal from moving averages despite neutral oscillators. The ETF maintains strong sector diversification and a 2.42% dividend yield, though recent news highlights competition from alternatives like SCHD and IDV. Support levels are clustered around $157-158, with resistance at $160-161.
Outlook remains mixed; VYM offers steady income but faces pressure from higher-yielding or better-performing peers. Key risks include dividend cuts in holdings like Intel and Walgreens, while institutional sentiment leans cautious due to moderate growth prospects versus competing ETFs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →
